Express News | Merck and Orion announced that Opevesostat will be exclusively licensed by Merck.

BreakingsJul 1 20:50

Market Whales and Their Recent Bets on MRK Options

Investors with a lot of money to spend have taken a bearish stance on Merck & Co (NYSE:MRK).And retail traders should know.We noticed this today when the positions showed up on publicly available opti

Benzinga36minutes ago

Express News | Merck Shares up 3.8%

BreakingsJul 1 21:56

Orion Upgrades FY24 Outlook After Modifying Agreement With Merck & Co

Orion (ORNAV.HE, ORNBV.HE) upwardly revised its full-year outlook after its development and commercialization deal with US-based Merck & Co was converted into a global license for the latter, accordin

MT NewswiresJul 1 21:23

Merck, Orion Convert Collaboration Into Exclusive License

By Colin Kellaher Merck & Co. and Finland's Orion have agreed to convert a 2022 co-development and co-commercialization agreement into an exclusive global license for Merck. The companies on Monday

WSJJul 1 20:50

Express News | N-Power Medicine: Collaborates With Merck to Expand Oncologist and Patient Access to Clinical Trials

BreakingsJul 1 20:21